vimarsana.com

Page 18 - நாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First day of trading with warrants of series TO4 B and TO5 B in Terranet has been set to May 21, 2021

(1) As previously communicated, TerraNet Holding AB ( Terranet or the Company ) has allocated one (1) warrant of series TO4 B to the Company s existing shareholders for every thirty-seven (37) shares owned on the record date, May 5, 2021, and one (1) warrant of series TO5 B for every forty-three (43) shares owned on the record date, May 14, 2021. First day of trading with warrants of series TO4 B and series TO5 B on Nasdaq First North Premier Growth Market has been set to May 21, 2021. Information and terms for the warrants Warrants of series TO4 B In total 14,319,634 warrants of series TO4 B have been issued, of which 7,159,817 warrants were issued to the lender Formue Nord Fokus A/S (the

Investegate |Terranet Announcements | Terranet: First day of trading with warrants of series TO4 B and TO5 B in Terranet has been set to May 21, 2021

Investegate |Terranet Announcements | Terranet: First day of trading with warrants of series TO4 B and TO5 B in Terranet has been set to May 21, 2021
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Isofol s Board of Directors resolves on a fully guaranteed preferential rights issue of approximately SEK 400 million

Isofol s Board of Directors resolves on a fully guaranteed preferential rights issue of approximately SEK 400 million News provided by Share this article GOTHENBURG, Sweden, May 18, 2021 /PRNewswire/   Isofol Medical AB s (publ), (Nasdaq First North Premier Growth Market: ISOFOL), ( Isofol or the Company ) Board of Directors has today, pursuant to the authorization granted by the extraordinary general meeting held on May 14, 2021 ( the EGM ), resolved on an issue of shares of a maximum of 62,524,474 shares with preferential rights for the Company s existing shareholders (the Rights Issue ). The subscription price in the Rights Issue is SEK 6.40 per share. If the Rights Issue is fully subscribed, the Company will receive approximately SEK 400 million before transaction costs related to the Rights Issue. In addition to the Rights Issue, and provided the Rights issue is oversubscribed, the Board of Directors is authorized to carry out a directed share issue with deviation from t

DGAP-Adhoc: Media and Games Invest plc: Evaluation of further debt capital raise to execute on it s M&A pipeline

DGAP-Adhoc: Media and Games Invest plc: Evaluation of further debt capital raise to execute on it s M&A pipeline
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Isofol s Board of Directors resolves on a fully guaranteed preferential rights issue of approximately SEK 400 million

Isofol s Board of Directors resolves on a fully guaranteed preferential rights issue of approximately SEK 400 million
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.